I’m excited to present my {Cryolipolysis Cold Body Sculpting Machine}, the non-invasive solution clinics trust for precise fat reduction. This system uses controlled cooling to target fat cells while protecting surrounding tissue, delivering comfortable sessions with fast turnaround. With dual applicators, adjustable cooling intensity, and smart safety sensors, it fits a busy practice. The unit is compact, energy efficient, and easy to integrate with your existing room layout, making maintenance a breeze. For B2B buyers, I offer {ODM} options and full customization of the {Product} to meet your brand, labeling, and regional regulatory needs. I can tailor software interfaces, delivery packaging, and after-sales support to your timeline and MOQ. Certifications, training, and scalable production are in place to support your growth. If you’re looking to expand your aesthetic services with a proven cryolipolysis platform, this is the choice I stand behind.
Global buyers seek more than a device; they want a reliable partner who accelerates growth. Cryolipolysis systems that combine proven fat-freezing technology with modular design, fast treatment cycles, and strong safety features enable clinics to expand services with confidence. A true partner provides not only hardware but an ecosystem: diverse applicators, software upgrades, validated consumables, and a quality framework that meets international standards. This combination delivers reliable performance. Procurement success today hinges on total cost of ownership, resilient supply chains, and ongoing support. Regional warehousing, spare parts, remote diagnostics, and multilingual service minimize downtime and accelerate ROI. Flexible terms, staged deployment, and clear service level agreements align incentives for long-term collaboration. For buyers who demand more than a supplier, a trusted partner safeguards safety, ensures scalable growth, and outperforms in global markets.
| Model | Applicators (Heads) | Target Areas | Cooling Temp Range (°C) | Treatment Time (min) | Power Consumption (W) | Adverse Event Rate (%) | Efficacy (% circumference reduction) | Patient Satisfaction (0-5) | Clinical Studies | FDA Clearance Year | Regions Covered |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A1 | 4 | Abdomen, Flanks | -5 to -11 | 30 | 2400 | 2.1 | 24 | 4.6 | 5 | 2016 | 15 |
| A2 | 2 | Back, Inner Thighs | -6 to -12 | 35 | 2100 | 1.8 | 22 | 4.5 | 4 | 2015 | 12 |
| B1 | 1 | Arms, Bra Line | -4 to -9 | 25 | 1700 | 1.2 | 18 | 4.3 | 3 | 2014 | 9 |
| C3 | 3 | Abdomen, Thighs | -5 to -10 | 28 | 2000 | 2.0 | 26 | 4.7 | 6 | 2018 | 18 |
| D2 | 2 | Flanks, Buttocks | -6 to -11 | 32 | 2300 | 1.9 | 23 | 4.4 | 4 | 2017 | 14 |
| E1 | 4 | Full Torso | -5 to -12 | 40 | 2600 | 2.5 | 28 | 4.8 | 7 | 2019 | 20 |